Phase 3 clinical trial results for ST-100 (vezocolmitide) ophthalmic solution, a novel dry eye candidate

Published on June 24, 2025
ST-100 shows promise as a fast-acting treatment for dry eye disease, offering rapid relief and unique collagen repair mechanisms.
Continue reading on website
Other news

Vision Expo announces move to a single annual event in 2026

June 24, 2025
Vision Expo, which has been traditionally split into regional East and West meetings, will transition to a single annual meeting that will rotate locations.

Chlorpromazine, Quetiapine Linked to Cataract Formation

June 25, 2025
A direct causal mechanism linking antipsychotics to cataract formation has not been established; however, one hypothesis is that they may affect signaling systems that increase protein aggregation in the lens, thus predisposing someone to cataract formation. Photo: Julie Tyler, OD. Click image to enlarge. Adverse events caused by any medication may sometimes be missed or go